study

(redirected from Dose-ranging study)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

study

1. a drawing, sculpture, etc., executed for practice or in preparation for another work
2. a musical composition intended to develop one aspect of performing technique
3. Theatre a person who memorizes a part in the manner specified

study

A drawing executed as an educational exercise, produced as a preliminary to a final work or made record observations.
See also: Design drawing

study

1. A room or alcove of a house or apartment used primarily as a place for reading, writing, and study. It often embodies the features of a private office and private library.
2. A preliminary sketch or drawing to facilitate the development of a design.
References in periodicals archive ?
Funded by Domain Associates, Adynxx has successfully completed a Phase 2 study of AYX1 for the prevention of pain following total knee replacement, and completed enrollment in a second Phase 2 dose-ranging study of AYX1 in Q2 2015.
The Phase 2 dose-ranging study is a multicenter, randomized, double-masked, placebo-controlled study with an optimized formulation of AMA0076 applied topically as eye-drops.
While the safety analysis showed no significant differences from placebo, there were two cases of cardiac disorders - one angina pectoris and one coronary artery disease - in the intravenous dose-ranging study and two cases listed as "cardiac disorders" in the regimen-finding study.
A second, dose-ranging study included 533 obese subjects who were randomized to placebo or taranabant in daily doses of 0.
In this dose-ranging study, AVE5026 was administered for up to 10 days for primary prevention of VTE in patients undergoing elective total knee replacement surgery.
Patients were eligible to continue on to the open-label study if no more than 14 days elapsed since their last dose in the dose-ranging study (Phase II) or the CONTAIN Trial.
Like the open-label Phase I clinical trial results at UCLA, this dose-ranging study demonstrates a statistically significant improvement in symptom severity, extends this finding under double-blind controlled conditions, and justifies further development of this intervention.
The Phase 2 dose-ranging study MT103-206 evaluated the efficacy, safety and tolerability of blinatumomab in adult patients with B-precursor Acute Lymphoblastic Leukemia who had relapsed following treatment with standard front-line chemotherapy or allogeneic stem cell transplant.
Tokyo, Japan, Sept 6, 2005 - (JCNN) - Sosei, a Japanese biopharmaceutical company, announced on September 5 that its wholly owned UK subsidiary Arakis has started a phase IIb dose-ranging study of AD 452, an investigational drug for the treatment of rheumatoid arthritis (RA).
BERLIN -- The investigational interleukin-1 inhibitor known as IL-1 trap has shown encouraging efficacy and safety in a phase II multicenter dose-ranging study of rheumatoid arthritis patients.
The ADXS-HPV CIN study is a randomized, single blind, placebo controlled Phase II dose-ranging study designed to assess the safety and efficacy in up to 3 different dose cohorts.
a clinical program designed to evaluate the safety / efficacy of ADASUVE in agitated adolescent patients - the initial study in this program, a Phase 1 dose-ranging study, has been initiated in collaboration with Teva and the first patient dosed